Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
J Nip, … , H R Shibata, P Brodt
J Nip, … , H R Shibata, P Brodt
Published May 1, 1995
Citation Information: J Clin Invest. 1995;95(5):2096-2103. https://doi.org/10.1172/JCI117897.
View: Text | PDF
Research Article Article has an altmetric score of 10

Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.

  • Text
  • PDF
Abstract

Integrin alpha v beta 3 is a marker of progression in malignant melanoma. Previously we reported that human melanoma cells derived from regional lymph node metastases had increased alpha v beta 3-mediated adhesion to lymph node vitronectin. In the present study, the expression and function of alpha v beta 3 were further investigated with emphasis on the functional relationship between alpha v beta 3 and the urokinase-type plasminogen activator system of proteolysis. We found that metastases-derived melanoma MeWo LNI 6I (6I) and MIM/8 LNI cells had a markedly increased expression of alpha v mRNA transcripts relative to the parent lines which was reflected in significantly elevated levels of the alpha v beta 3 heterodimers on the cell surface. These cells also expressed elevated levels of urokinase plasminogen activator receptor (uPAR) mRNA and had higher levels of surface bound urokinase plasminogen activator as detected by immunolabeling. To determine whether the expression of uPAR and alpha v were linked, alpha v synthesis in the metastatic melanoma cells was suppressed using alpha v antisense phosphorothioate oligonucleotides. This resulted in a marked decrease in detectable alpha v mRNA and protein and a corresponding substratum-specific reduction in cell adhesion to vitronectin. When uPAR expression in these cells was subsequently analyzed, we found a reduction of approximately 50% in uPAR mRNA levels. On the other hand, ligation of the alpha v beta 3 receptor on the melanoma cells by immobilized antibody resulted in a twofold increase in uPAR mRNA. The results suggest that the expression of uPAR in metastatic melanoma cells is linked to the expression and function of the vitronectin receptor.

Authors

J Nip, S A Rabbani, H R Shibata, P Brodt

×

Total citations by year

Year: 2025 2014 2013 2011 2010 2008 2006 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1993 Total
Citations: 1 1 1 1 1 3 1 2 4 3 5 7 2 14 9 5 1 1 62
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (62)

Title and authors Publication Year
Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type Cells
Serratì S, Zerlotin R, Manganelli M, Di Fonte R, Dicarlo M, Oranger A, Colaianni G, Porcelli L, Azzariti A, Guida S, Grano M, Colucci SC, Guida G
International Journal of Molecular Sciences 2025
Studies on primary uveal and cutaneous melanoma cell interaction with vitronectin: Melanoma cell interaction with vitronectin
ME Janik, A Lityńska, M Przybyło
Cell Biology International 2014
The cellular microenvironment modulates the role of PAI-1 and vitronectin in mediating cell-matrix interactions
S Goswami, LC Thompson, L Wickman, CB Peterson
Advances in Biological Chemistry 2013
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken
Advances in Cancer Research Volume 110 2011
Angiogenesis
TH Adair, JP Montani
Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2010
DNA tumour viruses promote tumour cell invasion and metastasis by deregulating the normal processes of cell adhesion and motility
MA Morris, LS Young, CW Dawson
European Journal of Cell Biology 2008
Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels
R Navab, C Pedraza, L Fallavollita, N Wang, E Chevet, P Auguste, S Jenna, Z You, A Bikfalvi, J Hu, R O'Connor, A Erickson, JS Mort, P Brodt
Oncogene 2008
Plasminogen activators are involved in the degradation of bone by osteoclasts
V Everts, E Daci, W Tigchelaar-Gutter, KA Hoeben, S Torrekens, G Carmeliet, W Beertsen
Bone 2008
Expression of alpha V integrin is modulated by Epstein–Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors
T Choudhuri, SC Verma, K Lan, ES Robertson
Virology 2006
Modulation of the urokinase-type plasminogen activator receptor by the β6 integrin subunit
N Dalvi, GJ Thomas, JF Marshall, M Morgan, R Bass, V Ellis, PM Speight, SA Whawell
Biochemical and Biophysical Research Communications 2004
Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention
WG Jiang, RE Mansel
2004
Urokinase Receptor Modulates Cellular and Angiogenic Responses in Obstructive Nephropathy
G Zhang, H Kim, X Cai, JM Lopez-Guisa, P Carmeliet, AA Eddy
Journal of the American Society of Nephrology : JASN 2003
Molecular and Functional Interdependence of the Urokinase-Type Plasminogen Activator System with Integrins
U Reuning, V Magdolen, S Hapke, M Schmitt
Biological Chemistry 2003
Angiogenesis in cutaneous melanoma: Pathogenesis and clinical implications
A Srivastava, R Ralhan, J Kaur
Microscopy Research and Technique 2003
Thrombospondin-1 and Cutaneous Melanoma
MJ Trotter, R Colwell, VA Tron
Journal of Cutaneous Medicine & Surgery 2003
Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating ?v?5 vitronectin receptor cell surface expression
I Silvestri, IL Cattani, P Franco, G Pirozzi, G Botti, MP Stoppelli, MV Carriero
International Journal of Cancer 2002
Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences
Y Adachi, N Chandrasekar, Y Kin, SS Lakka, S Mohanam, N Yanamandra, PM Mohan, GN Fuller, B Fang, J Fueyo, DH Dinh, WC Olivero, T Tamiya, T Ohmoto, AP Kyritsis, JS Rao
Oncogene 2002
Overexpression of αvβ6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade
N Ahmed, F Pansino, R Clyde, P Murthi, MA Quinn, GE Rice, MV Agrez, S Mok, MS Baker
Carcinogenesis 2002
Urokinase-Receptor/Integrin Complexes Are Functionally Involved in Adhesion and Progression of Human Breast Cancer in Vivo
G der Pluijm, B Sijmons, H Vloedgraven, C der Bent, JW Drijfhout, J Verheijen, P Quax, M Karperien, S Papapoulos, C Löwik
The American Journal of Pathology 2001
The role of the plasminogen activation system in angiogenesis and metastasis
SA Rabbani, AP Mazar
Surgical oncology clinics of North America 2001
Down-regulation of Integrin α v β 3 Expression and Integrin-mediated Signaling in Glioma Cells by Adenovirus-mediated Transfer of Antisense Urokinase-type Plasminogen Activator Receptor ( uPAR ) and Sense p16 Genes
Y Adachi, SS Lakka, N Chandrasekar, N Yanamandra, CS Gondi, S Mohanam, DH Dinh, WC Olivero, M Gujrati, T Tamiya, T Ohmoto, G Kouraklis, B Aggarwal, JS Rao
The Journal of biological chemistry 2001
α v Integrin, p38 Mitogen-activated Protein Kinase, and Urokinase Plasminogen Activator Are Functionally Linked in Invasive Breast Cancer Cells
J Chen, C Baskerville, Q Han, ZK Pan, S Huang
The Journal of biological chemistry 2001
The Receptor for the Type I Insulin-like Growth Factor and its Ligands Regulate Multiple Cellular Functions That Impact on Metastasis
AA Samani, P Brodt
Surgical oncology clinics of North America 2001
Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma
T Itoh, Y Hayashi, T Kanamaru, Y Morita, S Suzuki, W Wang, L Zhou, JA Rui, M Yamamoto, Y Kuroda, H Itoh
Journal of Gastroenterology and Hepatology 2000
Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor
N Montuori, S Salzano, G Rossi, P Ragno
FEBS Letters 2000
Suppressive Mechanism of Salmosin, a Novel Disintegrin in B16 Melanoma Cell Metastasis
IC Kang, DS Kim, Y Jang, KH Chung
Biochemical and Biophysical Research Communications 2000
An antisense oligonucleotide targeting the alphaV integrin gene inhibits adhesion and induces apoptosis in breast cancer cells
P A Townsend, I Villanova, E Uhlmann, A Peyman, J Knolle, R Baron, A Teti, M A Horton
European Journal of Cancer 2000
Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38α Mitogen-activated Protein Kinase Activity
S Huang, L New, Z Pan, J Han, GR Nemerow
The Journal of biological chemistry 2000
Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of αv integrins
S Huang, D Stupack, A Liu, D Cheresh, GR Nemerow
Oncogene 2000
Regulation of urokinase plasminogen activator/plasmin- mediated invasion of melanoma cells by the integrin vitronectin receptor α V β 3: Regulation of uPAR-Mediated Invasion by α v β 3
AM Khatib, J Nip, L Fallavollita, M Lehmann, G Jensen, P Brodt
International Journal of Cancer 2000
Oligodeoxynucleotide Targeted to the αv Gene Inhibits αv Integrin Synthesis, Impairs Osteoclast Function, and Activates Intracellular Signals to Apoptosis
I Villanova, PA Townsend, E Uhlmann, J Knolle, A Peyman, M Amling, R Baron, MA Horton, A Teti
Journal of Bone and Mineral Research 1999
Degradation of Extracellular Matrix by Metastatic Follicular Thyroid Carcinoma Cell Lines: Role of the Plasmin Activation System
JW Smit, GV der Pluijm, HA Romijn, CW Löwik, H Morreau, BM Goslings
Thyroid 1999
Adenoviral Gene Transfer of β3 Integrin Subunit Induces Conversion from Radial to Vertical Growth Phase in Primary Human Melanoma
MY Hsu, DT Shih, FE Meier, PV Belle, JY Hsu, DE Elder, CA Buck, M Herlyn
The American Journal of Pathology 1998
Presidential address: Beyond risk groups—A new look at differentiated thyroid cancer
B Cady
Surgery 1998
Integrins take partners: cross-talk between integrins and other membrane receptors
JC Porter, N Hogg
Trends in Cell Biology 1998
HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI
CN Rao, B Cook, Y Liu, K Chilukuri, MS Stack, DC Foster, W Kisiel, DT Woodley
International Journal of Cancer 1998
Proteases in cutaneous melanoma
CM Ferrier, GN van Muijen, DJ Ruiter
Annals of Medicine 1998
Urokinase type plasminogen activator receptor expression in colorectal neoplasms
S Suzuki, Y Hayashi, Y Wang, T Nakamura, Y Morita, K Kawasaki, K Ohta, N Aoyama, SR Kim, H Itoh, Y Kuroda, WF Doe
Gut 1998
Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma
MY Hsu, DT Shih, FE Meier, PV Belle, JY Hsu, DE Elder, CA Buck, M Herlyn
The American Journal of Pathology 1998
Expression of alphav integrins and vitronectin receptor identity in breast cancer cells
T Meyer, JF Marshall, IR Hart
British Journal of Cancer 1998
Suppression of Type I Collagenase Expression by Antisense RNA in Melanoma Cells Results in Reduced Synthesis of the Urokinase-Type Plasminogen Activator Receptor
M Durko, P Brodt
Biochemical and Biophysical Research Communications 1998
Characterization of the integrin αv gene promoter in mice
M Kambe, Y Miyamoto, M Hayashi
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1998
Enhanced Invasion and Liver Colonization by Lung Carcinoma Cells Overexpressing the Type 1 Insulin-Like Growth Factor Receptor
L Long, R Rubin, P Brodt
Experimental Cell Research 1998
Growth Factor–dependent Activation of αvβ3 Integrin in Normal Epithelial Cells: Implications for Tumor Invasion
L Trusolino, G Serini, G Cecchini, C Besati, FS Ambesi-Impiombato, PC Marchisio, RD Filippi
The Journal of Cell Biology 1998
β 3 -Integrins Rather Than β 1 -Integrins Dominate Integrin-Matrix Interactions Involved in Postinjury Smooth Muscle Cell Migration
MJ Slepian, SP Massia, B Dehdashti, A Fritz, L Whitesell
Circulation 1998
Phosphorylation stabilizes alternatively spliced CD44 mRNA transcripts in breast cancer cells: inhibition by antisense complementary to casein kinase II mRNA
B Formby, R Stern
Molecular and Cellular Biochemistry 1998
Melanoma cell migration on vitronectin: Regulation by components of the plasminogen activation system
A Stahl, BM Mueller
International Journal of Cancer 1997
Stereoisomere Peptid-Bibliotheken und Peptidmimetika zum Design von selektiven Inhibitoren des αv β3-Integrins für eine neuartige Krebstherapie
R Haubner, IH Kessler
Angewandte Chemie 1997
Dietary Coenzyme Q10 Supplementation Alters Platelet Size and Inhibits Human Vitronectin (CD51/CD61) Receptor Expression
VL Serebruany, JV Ordonez, WR Herzog, M Rohde, SA Mortensen, K Folkers, PA Gurbel
Journal of Cardiovascular Pharmacology 1997
Altered in vitro spreading and cytoskeletal organization in human glioma cells by downregulation of urokinase receptor
SK Chintala, S Mohanam, Y Go, B Venkaiah, R Sawaya, ZL Gokaslan, JS Rao
Molecular Carcinogenesis 1997
Is Axillary Lymph Node Dissection Necessary in Routine Management of Breast Cancer? No
B Cady
The Breast Journal 1997
Advances in Molecular and Cell Biology
KJ Clemetson
Advances in Molecular and Cell Biology 1997
The α v β 3 Integrin Regulates α 5 β 1 -mediated Cell Migration toward Fibronectin
KO Simon, EM Nutt, DG Abraham, GA Rodan, LT Duong
The Journal of biological chemistry 1997
Role of Axillary Dissection in Mammographically Detected Breast Cancer
FR Jamali, SH Kurtzman, PJ Deckers
Surgical oncology clinics of North America 1997
Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues
Z Szekanecz, GK Haines, AE Koch
Journal of clinical pathology 1997
Up-regulated expression of the β3 integrin and the 92-kDa gelatinase in human HT-144 melanoma cell tumors grown in nude mice
V Gouon, GC Tucker, L Kraus-Berthier, G Atassi, N Kieffer
International Journal of Cancer 1996
Biology of tumor cell invasion: Interplay of cell adhesion and matrix degradation
J Heino
International Journal of Cancer 1996
A polymeric form of fibronectin has antimetastatic effects against multiple tumor types
R Pasqualini, S Bourdoulous, E Koivunen, VL Woods, E Ruoslahti
Nature Medicine 1996
Integrin α3β1 can promote adhesion and spreading of metastatic breast carcinoma cells on the lymph node stroma
NJ Tawil, V Gowri, M Djoneidi, J Nip, S Carbonetto, P Brodt
International Journal of Cancer 1996
The Plasminogen Activation System in Tumour Invasion and Metastasis
TJ Vries, GN Muijen, DJ Ruiter
Pathology - Research and Practice 1996
The role of the integrin vitronectin receptor, ?v?3 in melanoma metastasis
J Nip, P Brodt
Cancer and Metastasis Reviews 1995
Role of integrins and other cell adhesion molecules in tumor progression and metastasis
P Keely, L Parise, R Juliano
Laboratory Investigation 1993

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 13 patents
18 readers on Mendeley
See more details